Skip to content

A randomised controlled trial of ACAT, a psychoeducational programme for adults with high-functioning autism spectrum disorder.

A randomised controlled trial of ACAT, a psychoeducational programme for adults with high-functioning autism spectrum disorder. - A randomised controlled trial of ACAT

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000043606
Enrollment
70
Registered
2021-03-17
Start date
2021-03-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High-functioning Autism Spectrum Disorders

Interventions

Cognitive behavior therapy Treatment as Usual18

Sponsors

Chiba University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Individual with who have diagnosis of autism spectrum disorder. 2)Verbal intelligence quotient of patients is over 90. 3)Individual with who are above "some need" in Strengths & Difficulties Questionnaires. 4)Age of patients is over 10 to 17 year 5)Caregivers can attend their CBT session with patients. 6)Individual with who have "treatment as usual" does not add an new treatment. 7)Patients can understand CBT. 8)The patients who are diagnosed anxiety disorder and depression can attend this study if they are primaly diagnosed of ASD. 9)Caregivers should not have any psychiatric deseases. 10)Caregivers can attend each CBT session with patients.

Exclusion criteria

Exclusion criteria: 1)Individual with who have an organic disorder 2)Individual with who have suicidal atempt. 3)Individual with who have antisocial conditions. 4)Individual with who have serious psycical disorder. 5)Individual with who have low IQ(under 90 of VIQ) 6)Individual with whoes caregivers cannot attend the sessions.

Design outcomes

Primary

MeasureTime frame
Adaptive Behavior Composite score for Japanese version of Vineland 2 at 6 weeks after intervention

Secondary

MeasureTime frame
Change from Week 0 (baseline) at 10 weeks for Communication, Daily Living Skills, Social Skills, and Total on the ineland-2 (Parent-Teacher Interview), and scores for each subfactor on the Seehan disability scale (SDISS) and change from Week 0 (baseline) at 6 weeks, change from Week 0 (baseline) at 10 weeks, Student Adaptation to College Questionnaire (SACQ) scores per subfactor, and psychiatric The Internalized Stigma of Illness Scale (ISMI), the total score of the "Stigma Scale" sub-item of the Barriers to Access to Care Evaluation v3 (BACE), and the Patient Health Patient Health Questionnaire-9 (PHQ-9: Depression Scale), Generalized Anxiety Disorder-7 (GAD-7: Anxiety Scale), Meta Cognitive Questionnaire 30 (MCQ30), the total score of Section 2 Knowlege of the Autism Knowledge Quiz for Children and Adolescents (AKQ-C), the total score of Section 3 Ethos of the Autism Knowledge Quiz for Children and Adolescents (AKQ-C), and the total score of the Camouflage Scale (The Camouflage Scale). Camouflaging Autistic Traits Questionnaire (CAT-Q), and scores for each subfactor of the Camouflaging Autistic Traits Questionnaire (CAT-Q).

Countries

Japan

Contacts

Public ContactOshima Fumiyo

Chiba University Research Center for Child Mental Development

f_oshima@chiba-u.jp043-226-2975

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026